Glenn Mattes

2020

In 2020, Glenn Mattes earned a total compensation of $3.4M as CEO at TFF Pharmaceuticals.

Compensation breakdown

Bonus$225,000
Option Awards$2,706,741
Salary$429,167
Total$3,360,908

Mattes received $2.7M in option awards, accounting for 81% of the total pay in 2020.

Mattes also received $225K in bonus and $429.2K in salary.

Rankings

In 2020, Glenn Mattes' compensation ranked 3,457th out of 13,090 executives tracked by ExecPay. In other words, Mattes earned more than 73.6% of executives.

ClassificationRankingPercentile
All
3,457
out of 13,090
74th
Division
Manufacturing
1,347
out of 5,621
76th
Major group
Chemicals And Allied Products
507
out of 2,254
78th
Industry group
Drugs
440
out of 1,954
78th
Industry
Pharmaceutical Preparations
330
out of 1,459
77th
Source: SEC filing on September 21, 2022.

Mattes' colleagues

We found two more compensation records of executives who worked with Glenn Mattes at TFF Pharmaceuticals in 2020.

2020

Christopher Cano

TFF Pharmaceuticals

Chief Operating Officer

2020

Kirk Coleman

TFF Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like